Cargando…

The development of a novel, multilingual IBD knowledge questionnaire for Asian patients with inflammatory bowel disease

BACKGROUND: Inflammatory bowel disease is an uncommon disease in developing nations whereby patient’s knowledge on the disease may be limited. The CCKNOW questionnaire, a widely known questionnaire to assess patient’s knowledge on the disease, may be too complex to comprehend for patients in develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Razima Wan Ibrahim, Nik, Danaee, Mahmoud, Khoo, Xin-Hui, Sithambaram, Suresh, Shahrani, Shahreedhan, Hwong-Ruey Leow, Alex, Chang, Jo-Ven, Francis Mayberry, John, Normiha Hilmi, Ida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210279/
https://www.ncbi.nlm.nih.gov/pubmed/37231353
http://dx.doi.org/10.1186/s12876-023-02817-0
_version_ 1785047035751170048
author Razima Wan Ibrahim, Nik
Danaee, Mahmoud
Khoo, Xin-Hui
Sithambaram, Suresh
Shahrani, Shahreedhan
Hwong-Ruey Leow, Alex
Chang, Jo-Ven
Francis Mayberry, John
Normiha Hilmi, Ida
author_facet Razima Wan Ibrahim, Nik
Danaee, Mahmoud
Khoo, Xin-Hui
Sithambaram, Suresh
Shahrani, Shahreedhan
Hwong-Ruey Leow, Alex
Chang, Jo-Ven
Francis Mayberry, John
Normiha Hilmi, Ida
author_sort Razima Wan Ibrahim, Nik
collection PubMed
description BACKGROUND: Inflammatory bowel disease is an uncommon disease in developing nations whereby patient’s knowledge on the disease may be limited. The CCKNOW questionnaire, a widely known questionnaire to assess patient’s knowledge on the disease, may be too complex to comprehend for patients in developing countries. The aim of this study is to develop a new tool known as AIBDKQ questionnaire to evaluate the local inflammatory bowel disease patient’s knowledge. METHODS: This was a prospective study carried out in four phases. In phase 1, three gastroenterologists with expertise in IBD generated a total of 21 questions related to the general knowledge of the disease in the English language. Phase 2 involved content and face validity whereby the questions were further validated by other gastroenterologists. In phase 3, the validated questions were translated into three languages namely Malay, Mandarin and Tamil which are commonly used in Malaysia. In phase 4 (statistical validity), administration of the questionnaires to patients and hospital staff were conducted to assess the construct validity, discriminative ability, predictive validity and reliability of the questionnaires. RESULTS: A total of 21 questions were generated initially. Further evaluation indicated that 20 items had adequate kappa and content validity index for relevance (CVI: 0.714 to 1, Kapp: 0.645 to 1) and clarity (CVI: 0.714 to 1, Kapp: 0.645 to 1). The questionnaires in four languages were administered to 213 patients to assess the construct validity. Six items were removed (three for low communality, one for small loading factors, two for cross loading), resulting in 16 final questions. Assessment with 34 hospital staff involving nurses, doctors and clerks showed significant differences in knowledge between the groups (F = 14.007, p < 0.001) and were able to discriminate doctors from nurses and clerks. Another group of 18 hospital staff administered with AIBDKQ and CCKNOW questionnaires showed a Pearson’s correlation coefficient of 0.8 indicating strong correlation and concurrent predictive validity between the two questionnaires. Final assessment with 38 patients for reliability assessment revealed high intraclass correlation of the questionnaire among the four languages. CONCLUSIONS: The AIBDKQ has an excellent discriminant ability and internal consistency with a strong correlation when compared to the standard CCKNOW questionnaire. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-023-02817-0.
format Online
Article
Text
id pubmed-10210279
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102102792023-05-26 The development of a novel, multilingual IBD knowledge questionnaire for Asian patients with inflammatory bowel disease Razima Wan Ibrahim, Nik Danaee, Mahmoud Khoo, Xin-Hui Sithambaram, Suresh Shahrani, Shahreedhan Hwong-Ruey Leow, Alex Chang, Jo-Ven Francis Mayberry, John Normiha Hilmi, Ida BMC Gastroenterol Research BACKGROUND: Inflammatory bowel disease is an uncommon disease in developing nations whereby patient’s knowledge on the disease may be limited. The CCKNOW questionnaire, a widely known questionnaire to assess patient’s knowledge on the disease, may be too complex to comprehend for patients in developing countries. The aim of this study is to develop a new tool known as AIBDKQ questionnaire to evaluate the local inflammatory bowel disease patient’s knowledge. METHODS: This was a prospective study carried out in four phases. In phase 1, three gastroenterologists with expertise in IBD generated a total of 21 questions related to the general knowledge of the disease in the English language. Phase 2 involved content and face validity whereby the questions were further validated by other gastroenterologists. In phase 3, the validated questions were translated into three languages namely Malay, Mandarin and Tamil which are commonly used in Malaysia. In phase 4 (statistical validity), administration of the questionnaires to patients and hospital staff were conducted to assess the construct validity, discriminative ability, predictive validity and reliability of the questionnaires. RESULTS: A total of 21 questions were generated initially. Further evaluation indicated that 20 items had adequate kappa and content validity index for relevance (CVI: 0.714 to 1, Kapp: 0.645 to 1) and clarity (CVI: 0.714 to 1, Kapp: 0.645 to 1). The questionnaires in four languages were administered to 213 patients to assess the construct validity. Six items were removed (three for low communality, one for small loading factors, two for cross loading), resulting in 16 final questions. Assessment with 34 hospital staff involving nurses, doctors and clerks showed significant differences in knowledge between the groups (F = 14.007, p < 0.001) and were able to discriminate doctors from nurses and clerks. Another group of 18 hospital staff administered with AIBDKQ and CCKNOW questionnaires showed a Pearson’s correlation coefficient of 0.8 indicating strong correlation and concurrent predictive validity between the two questionnaires. Final assessment with 38 patients for reliability assessment revealed high intraclass correlation of the questionnaire among the four languages. CONCLUSIONS: The AIBDKQ has an excellent discriminant ability and internal consistency with a strong correlation when compared to the standard CCKNOW questionnaire. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-023-02817-0. BioMed Central 2023-05-25 /pmc/articles/PMC10210279/ /pubmed/37231353 http://dx.doi.org/10.1186/s12876-023-02817-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Razima Wan Ibrahim, Nik
Danaee, Mahmoud
Khoo, Xin-Hui
Sithambaram, Suresh
Shahrani, Shahreedhan
Hwong-Ruey Leow, Alex
Chang, Jo-Ven
Francis Mayberry, John
Normiha Hilmi, Ida
The development of a novel, multilingual IBD knowledge questionnaire for Asian patients with inflammatory bowel disease
title The development of a novel, multilingual IBD knowledge questionnaire for Asian patients with inflammatory bowel disease
title_full The development of a novel, multilingual IBD knowledge questionnaire for Asian patients with inflammatory bowel disease
title_fullStr The development of a novel, multilingual IBD knowledge questionnaire for Asian patients with inflammatory bowel disease
title_full_unstemmed The development of a novel, multilingual IBD knowledge questionnaire for Asian patients with inflammatory bowel disease
title_short The development of a novel, multilingual IBD knowledge questionnaire for Asian patients with inflammatory bowel disease
title_sort development of a novel, multilingual ibd knowledge questionnaire for asian patients with inflammatory bowel disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210279/
https://www.ncbi.nlm.nih.gov/pubmed/37231353
http://dx.doi.org/10.1186/s12876-023-02817-0
work_keys_str_mv AT razimawanibrahimnik thedevelopmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT danaeemahmoud thedevelopmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT khooxinhui thedevelopmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT sithambaramsuresh thedevelopmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT shahranishahreedhan thedevelopmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT hwongrueyleowalex thedevelopmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT changjoven thedevelopmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT francismayberryjohn thedevelopmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT normihahilmiida thedevelopmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT razimawanibrahimnik developmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT danaeemahmoud developmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT khooxinhui developmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT sithambaramsuresh developmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT shahranishahreedhan developmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT hwongrueyleowalex developmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT changjoven developmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT francismayberryjohn developmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease
AT normihahilmiida developmentofanovelmultilingualibdknowledgequestionnaireforasianpatientswithinflammatoryboweldisease